Latest National Eye Institute Stories
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
CLEVELAND, April 28, 2011 /PRNewswire/ -- A new study published online today in The New England Journal of Medicine (NEJM) shows bevacizumab (Avastin) is as effective as ranibizumab (Lucentis), the current Food and Drug Administration-approved drug for treating age-related macular degeneration (AMD).
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
ST. LOUIS, June 15 /PRNewswire/ -- The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2).
Los Angeles Latino eye study is first to track eye disease incidence in Latino population.
Ranibizumab injections plus laser therapy results in dramatic visual improvement.
NEW YORK, April 12 /PRNewswire/ -- Scientists have shown that through eye exams at the crib-side, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children. See video from National Eye Institute at: http://inr.mediaseed.tv/NEI_37353 ROP is one of the most common causes of vision loss in children and affects an estimated 15,000 premature infants...
A large genetic study of age-related macular degeneration (AMD) has identified three new genes associated with this blinding eye diseaseâ€”two involved in the cholesterol pathway.
Scientists have shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children.
There are far more Americans diagnosed with nearsightedness than just three decades ago.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.